Predictive Value of E-PASS and POSSUM System for Esophageal Carcinoma Following Surgical Resection


  • #TS/ESO 01-O-6
  • Thoracic Surgery/Esophagus. SESSION-1
  • Oral

Predictive Value of E-PASS and POSSUM System for Esophageal Carcinoma Following Surgical Resection

Yu-Shang Yang, Long-Qi Chen

West China Hospital, Sichuan University, Chengdu, China

Date, time and location: 2018.05.25 13:30, Congress Hall, 2F–C

Abstract

Objectives: As the two common used risk-adjusted scoring system for surgery, E-PASS and POSSUM were insufficiently evaluated in esophagectomy for esophageal carcinoma. The aim of this report was to assess the predictive value of E-PASS and POSSUM following surgical resection for esophageal carcinoma.

Methods: We retrospectively reviewed the clinicopathologic characteristics of 309 ESCC patients who underwent curative resection as the primary treatment at West China Hospital of Sichuan University between June 2015 and February 2016.

Result: Morbidity rate of original group and validation group was 48% (98/200) and 51% (56/109), respectively. As compared with the POSSUM, the E-PASS is the more curative scoring system with a lager AUC (E-PASSS, AUC=0.665; POSSUM, AUC=0.563). The result of the evaluation of calibration in validation group showed that the excellent correlation between the estimated and observed mortality rates in individual disease (O/E=1.00±0.4).

Conclusion: The E-PASS scoring system may be more curative predictor in predicting complications after esophageal carcinoma following surgical resection.


To top